- Home
- FLGC vs GOVX Comparison
FLGC vs GOVX Comparison
Compare FLGC & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGC
- GOVX
- Stock Information
- Founded
- FLGC 2019
- GOVX 2001
- Country
- FLGC United States
- GOVX United States
- Employees
- FLGC N/A
- GOVX N/A
- Industry
- FLGC Biotechnology: Pharmaceutical Preparations
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- FLGC Health Care
- GOVX Health Care
- Exchange
- FLGC Nasdaq
- GOVX Nasdaq
- Market Cap
- FLGC 15.9M
- GOVX 15.5M
- IPO Year
- FLGC 2021
- GOVX N/A
- Fundamental
- Price
- FLGC $0.61
- GOVX $0.95
- Analyst Decision
- FLGC Buy
- GOVX Strong Buy
- Analyst Count
- FLGC 2
- GOVX 5
- Target Price
- FLGC $4.00
- GOVX $12.40
- AVG Volume (30 Days)
- FLGC 106.1K
- GOVX 1.5M
- Earning Date
- FLGC 08-11-2025
- GOVX 08-05-2025
- Dividend Yield
- FLGC N/A
- GOVX N/A
- EPS Growth
- FLGC N/A
- GOVX N/A
- EPS
- FLGC N/A
- GOVX N/A
- Revenue
- FLGC $53,260,000.00
- GOVX $5,591,576.00
- Revenue This Year
- FLGC N/A
- GOVX N/A
- Revenue Next Year
- FLGC N/A
- GOVX N/A
- P/E Ratio
- FLGC N/A
- GOVX N/A
- Revenue Growth
- FLGC N/A
- GOVX N/A
- 52 Week Low
- FLGC $0.42
- GOVX $0.73
- 52 Week High
- FLGC $2.11
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- FLGC 42.89
- GOVX 46.22
- Support Level
- FLGC $0.62
- GOVX $0.85
- Resistance Level
- FLGC $0.72
- GOVX $1.39
- Average True Range (ATR)
- FLGC 0.06
- GOVX 0.15
- MACD
- FLGC -0.01
- GOVX -0.02
- Stochastic Oscillator
- FLGC 14.79
- GOVX 18.52
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.